Literature DB >> 28911829

Influenza in Older Adults.

H Keipp Talbot1.   

Abstract

Annually, influenza viruses cause significant disease in older adults, varying with the virulence of the circulating strain, prior exposure to circulating strain, and influenza vaccine effectiveness. Older adults often present atypically (eg, without fever) and with complications of influenza infection such as chronic obstructive pulmonary disease and congestive heart failure exacerbations. Prevention methods include antiviral medications and vaccines. Current influenza vaccines have moderate effectiveness for the prevention of hospitalization, but newer more immunogenic vaccines designed for adults 65 years of age and older have been licensed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Antivirals; Influenza; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 28911829     DOI: 10.1016/j.idc.2017.07.005

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  19 in total

1.  [Clinical characteristics of influenza pneumonia in the elderly and relationship between D-dimer and disease severity].

Authors:  J Li; Y Xu; Y Y Wang; Z C Gao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-02-18

2.  Using GPS-enabled mobile phones to evaluate the associations between human mobility changes and the onset of influenza illness.

Authors:  Youngseob Eum; Eun-Hye Yoo
Journal:  Spat Spatiotemporal Epidemiol       Date:  2021-11-12

3.  Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.

Authors:  Eric J Chow; Melissa A Rolfes; Alissa O'Halloran; Evan J Anderson; Nancy M Bennett; Laurie Billing; Shua Chai; Elizabeth Dufort; Rachel Herlihy; Sue Kim; Ruth Lynfield; Chelsea McMullen; Maya L Monroe; William Schaffner; Melanie Spencer; H Keipp Talbot; Ann Thomas; Kimberly Yousey-Hindes; Carrie Reed; Shikha Garg
Journal:  Ann Intern Med       Date:  2020-08-25       Impact factor: 25.391

4.  Reduction in respiratory viral infections among hospitalized older adults during the COVID-19 pandemic.

Authors:  Jing Y Tan; Edwin P Conceicao; Liang E Wee; Jean X Y Sim; Indumathi Venkatachalam
Journal:  J Am Geriatr Soc       Date:  2021-04-23       Impact factor: 7.538

5.  Spatio-Temporal Analysis of Influenza-Like Illness and Prediction of Incidence in High-Risk Regions in the United States from 2011 to 2020.

Authors:  Zhijuan Song; Xiaocan Jia; Junzhe Bao; Yongli Yang; Huili Zhu; Xuezhong Shi
Journal:  Int J Environ Res Public Health       Date:  2021-07-02       Impact factor: 3.390

6.  Comparison of Vaccine Acceptance Between COVID-19 and Seasonal Influenza Among Women in China: A National Online Survey Based on Health Belief Model.

Authors:  Liyuan Tao; Ruitong Wang; Jue Liu
Journal:  Front Med (Lausanne)       Date:  2021-06-04

Review 7.  From virus to inflammation, how influenza promotes lung damage.

Authors:  Mitchell Klomp; Sumit Ghosh; Sohail Mohammed; M Nadeem Khan
Journal:  J Leukoc Biol       Date:  2020-09-08       Impact factor: 6.011

8.  Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care.

Authors:  Mithilesh Dronavalli; Heidi Lord; Kate Alexander; Leng Boonwaat; Narugopal Pal; Stephanie Mahalia Fletcher-Lartey
Journal:  J Epidemiol Glob Health       Date:  2020-06

Review 9.  Adult Immunization - Need of the Hour.

Authors:  Abhishek Jairaj; P Shirisha; Muqthadir Siddiqui Mohammad Abdul; Urooj Fatima; Rahul Vinay Chandra Tiwari; Muhamood Moothedath
Journal:  J Int Soc Prev Community Dent       Date:  2018-11-29

10.  Serological response to influenza vaccination among adults hospitalized with community-acquired pneumonia.

Authors:  Caroline Quinn Pratt; Yuwei Zhu; Carlos G Grijalva; Richard G Wunderink; D Mark Courtney; Grant Waterer; Min Z Levine; Stacie Jefferson; Wesley H Self; Derek J Williams; Lynn Finelli; Anna M Bramley; Kathryn M Edwards; Seema Jain; Evan J Anderson
Journal:  Influenza Other Respir Viruses       Date:  2018-12-17       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.